Chuanmin Chu

710 total citations
25 papers, 492 citations indexed

About

Chuanmin Chu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chuanmin Chu has authored 25 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Chuanmin Chu's work include Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers) and interferon and immune responses (3 papers). Chuanmin Chu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Ferroptosis and cancer prognosis (4 papers) and interferon and immune responses (3 papers). Chuanmin Chu collaborates with scholars based in China and United States. Chuanmin Chu's co-authors include Xiuwu Pan, Sishun Gan, Fajun Qu, Jianqing Ye, Xingang Cui, Qiwei Yang, Xingang Cui, Yinghao Sun, Yi Gao and Xiaopeng Duan and has published in prestigious journals such as Biomaterials, Scientific Reports and Cell Death and Differentiation.

In The Last Decade

Chuanmin Chu

22 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanmin Chu China 14 251 163 150 97 85 25 492
Mancheng Gong China 12 220 0.9× 177 1.1× 72 0.5× 81 0.8× 51 0.6× 21 520
Longwang Wang China 12 263 1.0× 154 0.9× 114 0.8× 85 0.9× 32 0.4× 25 461
Yunyan Sun China 14 323 1.3× 53 0.3× 122 0.8× 124 1.3× 103 1.2× 32 546
Marie Müller France 12 265 1.1× 173 1.1× 91 0.6× 148 1.5× 84 1.0× 30 546
D. Matthew Gianferante United States 4 302 1.2× 172 1.1× 203 1.4× 103 1.1× 54 0.6× 8 513
Zhumei Cui China 19 420 1.7× 58 0.4× 208 1.4× 150 1.5× 152 1.8× 43 739
Wangyu Cai China 14 447 1.8× 103 0.6× 233 1.6× 150 1.5× 58 0.7× 19 651
Flora D’Anna Germany 3 421 1.7× 64 0.4× 282 1.9× 63 0.6× 50 0.6× 4 619
Min Pan China 12 334 1.3× 61 0.4× 153 1.0× 213 2.2× 85 1.0× 35 613

Countries citing papers authored by Chuanmin Chu

Since Specialization
Citations

This map shows the geographic impact of Chuanmin Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanmin Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanmin Chu more than expected).

Fields of papers citing papers by Chuanmin Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanmin Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanmin Chu. The network helps show where Chuanmin Chu may publish in the future.

Co-authorship network of co-authors of Chuanmin Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanmin Chu. A scholar is included among the top collaborators of Chuanmin Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanmin Chu. Chuanmin Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Chuanmin, Bing-Nan Lu, Muchen Li, et al.. (2025). Bioinformatic analysis and retrospective clinical study identifying DNAJB4 as a pan-cancer biomarker with a highlight on kidney cancer. Clinical and Experimental Medicine. 25(1). 260–260.
3.
Wang, Tao, Juanjuan Sun, Lei Dong, et al.. (2025). Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors. Cell & Bioscience. 15(1). 40–40. 1 indexed citations
4.
Ju, Guanqun, Xinglin Chen, Tongtong Zhang, et al.. (2024). Bisphenol S enhances the cell proliferation ability of prostate cancer cells by regulating the expression of SDS. Toxicology in Vitro. 98. 105827–105827. 5 indexed citations
5.
Ma, Cheng, Xinyu Zhai, Guanqun Ju, et al.. (2024). Exploring the role of eIF3m in prostate cancer: regulation of c-Myc signaling pathway and therapeutic implications. Neoplasma. 71(5). 442–450.
6.
Du, Yang, et al.. (2022). The inhibition of TRIM35-mediated TIGAR ubiquitination enhances mitochondrial fusion and alleviates renal ischemia-reperfusion injury. International Journal of Biological Macromolecules. 209(Pt A). 725–736. 10 indexed citations
7.
Chen, Jiaxin, Da Xu, Jianwei Cao, et al.. (2021). TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination. Cancer Cell International. 21(1). 129–129. 28 indexed citations
8.
Ning, Jinzhuo, Chuanmin Chu, Yang Du, & Li Zuo. (2021). MiR-25 regulates cell proliferation and metastasis in bladder urothelial carcinoma. Journal of Cancer. 12(22). 6706–6714. 3 indexed citations
9.
Wang, Chao, Yuning Wang, Jianqing Ye, et al.. (2020). Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma. Cell Death and Differentiation. 28(3). 932–951. 31 indexed citations
10.
Yang, Qiwei, Weiwei Chu, Wei Yang, et al.. (2020). Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis. Frontiers in Genetics. 11. 540094–540094. 18 indexed citations
11.
Wang, Yuning, Chuanmin Chu, Jiangbo Zhu, et al.. (2020). The natural extract degalactotigonin exerts antitumor effects on renal cell carcinoma cells through repressing YAP. Translational Cancer Research. 9(12). 7550–7561. 5 indexed citations
12.
Xu, Da, Hao Zhang, Haiyi Gong, et al.. (2020). Identification of a Potential Mechanism of Acute Kidney Injury During the Covid-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis. 20 indexed citations
13.
Pan, Xiuwu, Hao Zhang, Da Xu, et al.. (2020). Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis. International Journal of Biological Sciences. 16(16). 3149–3162. 43 indexed citations
15.
Wang, Chao, Yan Li, Chuanmin Chu, et al.. (2018). Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma. EBioMedicine. 39. 255–264. 17 indexed citations
16.
Qu, Fajun, Jianqing Ye, Xiuwu Pan, et al.. (2018). MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma. Journal of drug targeting. 27(1). 67–74. 47 indexed citations
17.
18.
Gan, Sishun, Jian-Qing Ye, Fajun Qu, et al.. (2017). Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells. OncoTargets and Therapy. Volume 10. 2139–2146. 37 indexed citations
20.
Pan, Xiuwu, Sishun Gan, Jian-Qing Ye, et al.. (2016). SMC1A promotes growth and migration of prostate cancer in vitro and in vivo. International Journal of Oncology. 49(5). 1963–1972. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026